Samlyn Capital’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,929,195
| Closed | -$17.6M | – | 114 |
|
|
2022
Q3 | $17.6M | Sell |
2,929,195
-15,060
| -0.5% | -$90.4K | 0.33% | 62 |
|
|
2022
Q2 | $12.2M | Buy |
2,944,255
+149,046
| +5% | +$617K | 0.24% | 67 |
|
|
2022
Q1 | $10.6M | Buy |
2,795,209
+1,025,355
| +58% | +$3.9M | 0.15% | 82 |
|
|
2021
Q4 | $7.96M | Buy |
1,769,854
+53,787
| +3% | +$242K | 0.11% | 84 |
|
|
2021
Q3 | $8M | Buy |
1,716,067
+132,178
| +8% | +$616K | 0.11% | 91 |
|
|
2021
Q2 | $11.2M | Buy |
1,583,889
+351,495
| +29% | +$2.48M | 0.16% | 76 |
|
|
2021
Q1 | $7.28M | Buy |
+1,232,394
| New | +$7.28M | 0.1% | 97 |
|